FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1888444958> ?p ?o ?g. }

• W1888444958 abstract "Pre-eclampsia is a relatively common complication of pregnancy. HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome is a severe manifestation of pre-eclampsia with significant morbidity and mortality for pregnant women and their children. Corticosteroids are commonly used in the treatment of HELLP syndrome in the belief that they improve outcomes.To determine the effects of corticosteroids on women with HELLP syndrome and their children.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 June 2010).Randomized controlled trials comparing any corticosteroid with placebo, no treatment, or other drug; or comparing one corticosteroid with another corticosteroid or dosage in women with HELLP syndrome.Two review authors assessed trial quality and extracted data independently.Eleven trials (550 women) compared corticosteroids with placebo or no treatment. There was no difference in the risk of maternal death (risk ratio (RR) 0.95, 95% confidence interval (CI) 0.28 to 3.21), maternal death or severe maternal morbidity (RR 0.27, 95% CI 0.03 to 2.12), or perinatal/infant death (RR 0.64, 95% CI 0.21 to 1.97). The only clear effect of treatment on individual outcomes was improved platelet count (standardized mean difference (SMD) 0.67, 95% CI 0.24 to 1.10). The effect on platelet count was strongest for women who commenced treatment antenatally (SMD 0.80, 95% CI 0.25 to 1.35).Two trials (76 women) compared dexamethasone with betamethasone. There was no clear evidence of a difference between groups in respect to perinatal/infant death (RR 0.95, 95% CI 0.15 to 6.17) or severe perinatal/infant morbidity or death (RR 0.64, 95% CI 0.27 to 1.48). Maternal death and severe maternal morbidity were not reported. In respect to platelet count, dexamethasone was superior to betamethasone (MD 6.02, 95% CI 1.71 to 10.33), both when treatment was commenced antenatally (MD 8.10, 95% CI 6.23 to 9.97) and postnatally (MD 3.70, 95% CI 0.96 to 6.44).There was no clear evidence of any effect of corticosteroids on substantive clinical outcomes. Those receiving steroids showed significantly greater improvement in platelet counts which was greater for those receiving dexamethasone than those receiving betamethasone. There is to date insufficient evidence of benefits in terms of substantive clinical outcomes to support the routine use of steroids for the management of HELLP. The use of corticosteroids may be justified in clinical situations in which increased rate of recovery in platelet count is considered clinically worthwhile." @default.
• W1888444958 created "2016-06-24" @default.
• W1888444958 creator A5016872796 @default.
• W1888444958 creator A5033165633 @default.
• W1888444958 creator A5039423576 @default.
• W1888444958 creator A5056992264 @default.
• W1888444958 date "2010-09-08" @default.
• W1888444958 modified "2023-10-01" @default.
• W1888444958 title "Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy" @default.
• W1888444958 cites W1595184853 @default.
• W1888444958 cites W1598602811 @default.
• W1888444958 cites W1764176278 @default.
• W1888444958 cites W1966422643 @default.
• W1888444958 cites W1968298785 @default.
• W1888444958 cites W1973795002 @default.
• W1888444958 cites W1984032752 @default.
• W1888444958 cites W1985979864 @default.
• W1888444958 cites W1995481300 @default.
• W1888444958 cites W2009388851 @default.
• W1888444958 cites W2009736590 @default.
• W1888444958 cites W2032534906 @default.
• W1888444958 cites W2036214011 @default.
• W1888444958 cites W2042564701 @default.
• W1888444958 cites W2051773312 @default.
• W1888444958 cites W2059018989 @default.
• W1888444958 cites W2059277748 @default.
• W1888444958 cites W2079431894 @default.
• W1888444958 cites W2089690948 @default.
• W1888444958 cites W2114166433 @default.
• W1888444958 cites W2124179853 @default.
• W1888444958 cites W2127347333 @default.
• W1888444958 cites W2135243145 @default.
• W1888444958 cites W2145478586 @default.
• W1888444958 cites W2148393304 @default.
• W1888444958 cites W2162306390 @default.
• W1888444958 cites W3130086887 @default.
• W1888444958 cites W4250266603 @default.
• W1888444958 cites W4256255843 @default.
• W1888444958 doi "https://doi.org/10.1002/14651858.cd008148.pub2" @default.
• W1888444958 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4171033" @default.
• W1888444958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20824872" @default.
• W1888444958 hasPublicationYear "2010" @default.
• W1888444958 type Work @default.
• W1888444958 sameAs 1888444958 @default.
• W1888444958 citedByCount "94" @default.
• W1888444958 countsByYear W18884449582012 @default.
• W1888444958 countsByYear W18884449582013 @default.
• W1888444958 countsByYear W18884449582014 @default.
• W1888444958 countsByYear W18884449582015 @default.
• W1888444958 countsByYear W18884449582016 @default.
• W1888444958 countsByYear W18884449582017 @default.
• W1888444958 countsByYear W18884449582018 @default.
• W1888444958 countsByYear W18884449582019 @default.
• W1888444958 countsByYear W18884449582020 @default.
• W1888444958 countsByYear W18884449582021 @default.
• W1888444958 countsByYear W18884449582022 @default.
• W1888444958 countsByYear W18884449582023 @default.
• W1888444958 crossrefType "journal-article" @default.
• W1888444958 hasAuthorship W1888444958A5016872796 @default.
• W1888444958 hasAuthorship W1888444958A5033165633 @default.
• W1888444958 hasAuthorship W1888444958A5039423576 @default.
• W1888444958 hasAuthorship W1888444958A5056992264 @default.
• W1888444958 hasBestOaLocation W18884449582 @default.
• W1888444958 hasConcept C126322002 @default.
• W1888444958 hasConcept C131872663 @default.
• W1888444958 hasConcept C142724271 @default.
• W1888444958 hasConcept C168563851 @default.
• W1888444958 hasConcept C204787440 @default.
• W1888444958 hasConcept C27081682 @default.
• W1888444958 hasConcept C2779234561 @default.
• W1888444958 hasConcept C2779703513 @default.
• W1888444958 hasConcept C2780537801 @default.
• W1888444958 hasConcept C2781162121 @default.
• W1888444958 hasConcept C2781276381 @default.
• W1888444958 hasConcept C2908647359 @default.
• W1888444958 hasConcept C2908892503 @default.
• W1888444958 hasConcept C44249647 @default.
• W1888444958 hasConcept C54355233 @default.
• W1888444958 hasConcept C71924100 @default.
• W1888444958 hasConcept C82789193 @default.
• W1888444958 hasConcept C86803240 @default.
• W1888444958 hasConcept C99454951 @default.
• W1888444958 hasConceptScore W1888444958C126322002 @default.
• W1888444958 hasConceptScore W1888444958C131872663 @default.
• W1888444958 hasConceptScore W1888444958C142724271 @default.
• W1888444958 hasConceptScore W1888444958C168563851 @default.
• W1888444958 hasConceptScore W1888444958C204787440 @default.
• W1888444958 hasConceptScore W1888444958C27081682 @default.
• W1888444958 hasConceptScore W1888444958C2779234561 @default.
• W1888444958 hasConceptScore W1888444958C2779703513 @default.
• W1888444958 hasConceptScore W1888444958C2780537801 @default.
• W1888444958 hasConceptScore W1888444958C2781162121 @default.
• W1888444958 hasConceptScore W1888444958C2781276381 @default.
• W1888444958 hasConceptScore W1888444958C2908647359 @default.
• W1888444958 hasConceptScore W1888444958C2908892503 @default.
• W1888444958 hasConceptScore W1888444958C44249647 @default.
• W1888444958 hasConceptScore W1888444958C54355233 @default.
• W1888444958 hasConceptScore W1888444958C71924100 @default.
• W1888444958 hasConceptScore W1888444958C82789193 @default.
• W1888444958 hasConceptScore W1888444958C86803240 @default.

• next